Net gamma exposure for Zymeworks Inc (ZYME) options was positive at the Nov 12, 2026 close, about $13.58K per 1% move in the stock. It has been positive on 1 of the last 20 trading days. With positive gamma, dealer hedging tends to lean against price moves, which can dampen swings.
Upgrade to unlock Gamma Flip, Gamma Profile, Call Wall, Put Wall, and multiple expiration dates.
Gamma Exposure by Strike
Showing results for ZYME, 2026-11-20(m), calls & puts
Gamma Exposure Stats
Showing results for ZYME, 2026-11-20(m), calls & puts
| Net GEX ($ per 1% move) | $25.0K |
|---|---|
| Call GEX ($ per 1% move) | $35.88K |
| Put GEX ($ per 1% move) | -$10.88K |
| Call Wall | |
| Put Wall | |
| Gamma Flip (Zero Gamma) |
Net Gamma Exposure by Expiration
Showing results for ZYME, 2026-11-20(m), calls & puts. View all expiries
| Expiration | Net GEX | Call GEX | Put GEX | Call Wall | Put Wall | Gamma Flip |
|---|---|---|---|---|---|---|
| Nov 20, 2026 7 DTE monthly | $25.0K | $35.88K | -$10.88K |
ZYME Gamma Exposure FAQ
What is gamma exposure (GEX)?
Gamma exposure estimates how much stock option dealers must buy or sell to stay hedged for each 1% move in the underlying.
Is ZYME gamma exposure positive or negative?
Zymeworks net gamma exposure was positive on Nov 12, 2026, at $13.58K. It has been positive on 1 of the last 20 trading days.
How has ZYME gamma exposure changed recently?
Zymeworks net gamma exposure went from -$386.69K on Oct 15, 2026 to $13.58K on Nov 12, 2026. That is its highest reading in 8 weeks. See the ZYME gamma exposure history for a longer view.
What is Zymeworks Inc?
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics.